Editorial: Novel Strategies for Anti-Tumor Vaccines.
作者信息
Accolla Roberto S, Buonaguro Luigi, Melief Cornelis, Rammensee Hans-George, Bassani-Sternberg Michal
机构信息
Department of Medicine and Surgery, School of Medicine, University of Insubria, Varese, Italy.
Cancer Immunoregulation Unit, Istituto Nazionale Tumori, IRCCS, "Fond G. Pascale", Naples, Italy.
出版信息
Front Immunol. 2020 Jan 17;10:3117. doi: 10.3389/fimmu.2019.03117. eCollection 2019.
Abstract
摘要
相似文献
1
Editorial: Novel Strategies for Anti-Tumor Vaccines.社论：抗肿瘤疫苗的新策略
Front Immunol. 2020 Jan 17;10:3117. doi: 10.3389/fimmu.2019.03117. eCollection 2019.
2
Therapeutic cancer vaccines: From initial findings to prospects.治疗性癌症疫苗：从初步发现到展望。
Immunol Lett. 2018 Apr;196:11-21. doi: 10.1016/j.imlet.2018.01.011. Epub 2018 Feb 4.
3
Neoantigen vaccine: an emerging tumor immunotherapy.肿瘤新生抗原疫苗：一种新兴的肿瘤免疫疗法。
Mol Cancer. 2019 Aug 23;18(1):128. doi: 10.1186/s12943-019-1055-6.
4
The present status and future prospects of peptide-based cancer vaccines.基于肽的癌症疫苗的现状与未来前景。
Int Immunol. 2016 Jul;28(7):319-28. doi: 10.1093/intimm/dxw027. Epub 2016 May 28.
5
A power surge for cancer immunotherapy: antibodies, vaccines, and engineered T cells fuel new optimism.癌症免疫疗法的一股强大动力：抗体、疫苗和工程化T细胞带来新的乐观情绪。
Cancer Cytopathol. 2014 Jan;122(1):1-2. doi: 10.1002/cncy.21390.
6
Personalized neoantigen vaccines: A new approach to cancer immunotherapy.个体化新抗原疫苗：癌症免疫治疗的新途径。
Bioorg Med Chem. 2018 Jun 1;26(10):2842-2849. doi: 10.1016/j.bmc.2017.10.021. Epub 2017 Oct 19.
7
Neoantigen Vaccines Pass the Immunogenicity Test.新抗原疫苗通过免疫原性测试。
Trends Mol Med. 2017 Oct;23(10):869-871. doi: 10.1016/j.molmed.2017.08.007. Epub 2017 Aug 31.
8
Methods for improving the immunogenicity and efficacy of cancer vaccines.提高癌症疫苗免疫原性和疗效的方法。
Expert Opin Biol Ther. 2018 Jul;18(7):765-784. doi: 10.1080/14712598.2018.1485649. Epub 2018 Jun 17.
9
IL-13 receptor-directed cancer vaccines and immunotherapy.白细胞介素-13 受体导向的癌症疫苗和免疫疗法。
Immunotherapy. 2012 Apr;4(4):443-51. doi: 10.2217/imt.12.28.
10
Next generation approaches for tumor vaccination.肿瘤疫苗接种的新一代方法。
Chin Clin Oncol. 2017 Apr;6(2):19. doi: 10.21037/cco.2017.02.04.
引用本文的文献
1
PLGA- Polysaccharide Nanovaccines Exert Therapeutic Effect in Colorectal Cancer.PLGA-多糖纳米疫苗在结直肠癌中发挥治疗作用。
Int J Nanomedicine. 2024 Sep 12;19:9437-9458. doi: 10.2147/IJN.S479334. eCollection 2024.
2
Trichostatin A-modified vaccine provides superior protection against ovarian cancer formation and development.曲古抑菌素 A 修饰疫苗可提供针对卵巢癌形成和发展的更佳保护。
Braz J Med Biol Res. 2024 May 17;57:e12874. doi: 10.1590/1414-431X2024e12874. eCollection 2024.
3
Senescent cancer cell-derived nanovesicle as a personalized therapeutic cancer vaccine.衰老癌细胞衍生的纳米囊泡作为一种个性化治疗性癌症疫苗。
Exp Mol Med. 2023 Mar;55(3):541-554. doi: 10.1038/s12276-023-00951-z. Epub 2023 Mar 1.
4
Therapeutic targets and biomarkers of tumor immunotherapy: response versus non-response.肿瘤免疫治疗的治疗靶点和生物标志物：反应与无反应。
Signal Transduct Target Ther. 2022 Sep 19;7(1):331. doi: 10.1038/s41392-022-01136-2.
5
Signal pathways and precision therapy of small-cell lung cancer.小细胞肺癌的信号通路与精准治疗。
Signal Transduct Target Ther. 2022 Jun 15;7(1):187. doi: 10.1038/s41392-022-01013-y.
6
Bedside formulation of a personalized multi-neoantigen vaccine against mammary carcinoma.针对乳腺癌的个体化多新抗原疫苗的床边配方。
J Immunother Cancer. 2022 Jan;10(1). doi: 10.1136/jitc-2021-002927.
本文引用的文献
1
Is It Possible to Develop Cancer Vaccines to Neoantigens, What Are the Major Challenges, and How Can These Be Overcome? Neoantigens: Nothing New in Spite of the Name.是否有可能针对新抗原开发癌症疫苗，主要挑战是什么，以及如何克服这些挑战？新抗原：名副其实的“并非新生事物”。
Cold Spring Harb Perspect Biol. 2018 Nov 1;10(11):a028829. doi: 10.1101/cshperspect.a028829.
Zotero 插件